SG Americas Securities
QTTB icon

SG Americas Securities’s Q32 Bio QTTB Stock Holding History

SG Americas Securities’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-986
Closed -$65K – 3524
2021
Q4 		$65K Sell
986
-694
-41% -$67.4K ﹤0.01% 3160
2021
Q3 		$238K Buy
+1,680
New +$214K ﹤0.01% 3110
2020
Q3 		– Sell
-471
Closed -$129K – 3544
2020
Q2 		$129K Buy
471
+101
+27% +$26.9K ﹤0.01% 3200
2020
Q1 		$104K Buy
+370
New +$113K ﹤0.01% 2977

Other funds holding QTTB

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

SG Americas Securities's QTTB Position: Q1 2022 in Review

SG Americas Securities sold out of Q32 Bio (QTTB) in Q1 2022, closing a stake of 986 shares — an estimated $65K sold.

SG Americas Securities first reported a position in QTTB in Q1 2020 and held it in 4 quarters. The position peaked at $238K in Q3 2021. 106 funds tracked by Wall St. Rank hold QTTB as of Q1 2022.

  • SG Americas Securities reported no remaining Q32 Bio position as of Q1 2022 after selling out during the quarter.
  • SG Americas Securities sold 986 Q32 Bio shares in Q1 2022, an estimated $65K.
  • SG Americas Securities first reported a position in Q32 Bio in Q1 2020 and held it in 4 quarters.
  • SG Americas Securities's Q32 Bio position peaked at $238K in Q3 2021.
  • 106 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2022.

Based on SG Americas Securities's 13F filing for Q1 2022, filed 29 Apr 2022.